We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Calcitonin-containing medicines should no longer be used in treatment of osteoporosis.
This enforcement policy sets out the general principles and approach taken by the VMD.
Projects granted during 2015 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.
Information on acrylonitrile (2-propenenitrile; cyanoethylene; vinyl cyanide) for use in responding to chemical incidents.
With the exception of medicines containing zidovudine, stavudine, or didanosine, product information will no longer include warnings on fat redistribution or lactic acidosis.
This report is an update of HPA-RPD-017 (2006), and provides a summary of data from UK human volunteer plutonium biokinetic studies.
This report (PHE-CRCE-030) provides scientific evidence to support advice about ultraviolet radiation (UVR) exposures and vitamin D
Medicines or herbal remedies that induce CYP3A4 enzymes reduce blood levels of levonorgestrel, which may reduce emergency contraceptive efficacy.
Information on bromine, for responding to chemical incidents.
Projects granted during 2016 that have a primary purpose of basic research: multisystemic and other.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The maximum recommended dose for simvastatin in conjunction with amlodipine and diltiazem is now 20 mg/day.
Information on trichloroethylene (also known as trichloroethene), for use in responding to chemical incidents.
Do not use codeine in children under 12 as it is associated with a risk of respiratory side effects. Codeine is not recommended for adolescents (12 to 18) who have problems with breathing.
This guidance explains what is required of health professionals carrying out newborn blood spot (NBS) screening.
Aceclofenac is now contraindicated in patients with certain established cardiovascular diseases.
Zentiva Pharma UK Limited is recalling the above batch of Co-codamol 30/500 Effervescent Tablets as a precautionary measure due to an issue with the homogeneity of the batch. This issue means that there is the potential…
Projects granted during 2016 that have a primary purpose of basic research, immune system.
…Patients with diabetes may experience symptomatic hypoglycaemia if diabetic treatment is continued at the same dose due to potential for an enhanced hypoglycaemic effect.
Quinine has dose-dependent QT-interval-prolonging effects and should be used with caution in patients with risk factors for QT prolongation or in those with atrioventricular block.…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).